Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Faith and First Responders: How Believing in a Higher Power Can Promote Healing Antioch, CA, September 23, 2022 — If he were given a chance to travel back in time, make different choices and avoid a prison sentence, Norm Wielsch says he would decline the offer. In 2013, the former undercover narcotic agent was sentenced … Continue reading Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Faith and First Responders: How Believing in a Higher Power Can Promote Healing Antioch, CA, September 23, 2022 — If he were given a chance to travel back in time, make different choices and avoid a prison sentence, Norm Wielsch says he would decline the offer. In 2013, the former undercover narcotic agent was sentenced … Continue reading Faith and First Responders: How Believing in a Higher Power Can Promote Healing
Celebrating 10 Years of Pharmacist Enabled Clinical Care in Alberta
Celebrating 10 Years of Pharmacist Enabled Clinical Care in Alberta EDMONTON, AB, Sept. 23, 2022 /CNW/ – On September 25, 2022, we celebrate World Pharmacists Day and this year’s theme of “Pharmacy United in Action for a Healthier World.” Alberta has been and continues to be a leader in the profession of pharmacist practice, with a practice … Continue reading Celebrating 10 Years of Pharmacist Enabled Clinical Care in Alberta
Health Canada approves Takeda’s LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection
Health Canada approves Takeda’s LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection TORONTO, Sept. 20, 2022 /CNW/ – Takeda Canada Inc. (“Takeda”) is pleased to announce that Health Canada has authorized (Notice of Compliance) LIVTENCITY™ (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) infection/disease who are refractory (with or without genotypic … Continue reading Health Canada approves Takeda’s LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection
QEII Foundation to announce transformational gift for cancer care innovation
QEII Foundation to announce transformational gift for cancer care innovation HALIFAX, NS, Sept. 20, 2022 /CNW/ – On Thursday, September 22, the QEII Foundation will announce its largest donation ever received to-date – a multimillion-dollar transformational gift that will impact cancer care in Atlantic Canada for generations to come. One local family’s incredible generosity will … Continue reading QEII Foundation to announce transformational gift for cancer care innovation
